Related by context. Frequent words. (Click for all words.) 62 OR SIMILAR STATEMENTS ARE 60 ZFP Therapeutic 59 PLAN OR EXPECT 59 PEG PAL PEGylated recombinant 58 inflammatory autoimmune diseases 57 phenylalanine ammonia lyase 57 RXi Pharmaceutical Corporation 57 within themeaning 57 SAFE HARBOR PROVISIONS OF 57 * Potentially libelous 56 UNITED STATES SECURITIES ACT 56 Inovio clinical 55 f h 55 involving hydrophilic liquid 55 successfully commercialize REOLYSIN 55 concerning Alnylam 54 THE PRIVATE SECURITIES LITIGATION 54 HPV cervical cancer 54 INFORMATION CONTAINED HEREIN 54 y r 54 suchforward looking 54 male hypogonadism licensed 54 i g 54 PINNACLEDIGEST.COM S PAST PERFORMANCE 54 Entereg R 54 STATEMENTS AND 54 R sorafenib tablets 53 WHICH ARE NOT PURELY 53 Statements Certain 53 using BioSante patented 53 Legislation Reform Act 53 Offering Pilates 53 -leukemias 53 LIMITATION MAY NOT APPLY 53 AND SHOULD ALSO 53 Staff Writer jschramm@minotdailynews.com 53 cell hESC 53 CONTAIN FORWARD LOOKING STATEMENTS 52 BlackRock cautions 52 YOU IN RELIANCE 52 y h 52 spammatory 52 negatives thereof 52 TranSwitch indebtedness 52 h y 52 HISTORICAL ARE FORWARD LOOKING 52 y u 52 Statements Statements 51 OF THE SUBSTANCE 51 Attribution Policy 51 UNDER THE PRIVATE 51 THE EXPRESSED WRITTEN CONSENT 51 NEBIDO R 51 development diagnostics combinatorial 51 g h 51 Nanobac Pharmaceuticals Inc. 51 REPORTS FILED FROM 51 acquisitions divestitures mergers 51 h u 51 ATK undertakes 51 VERBINDLICH IST AUSSCHLIESSLICH DIE 51 Embryome Sciences 51 u t 51 Supports relaxing 51 Powerwave Powerwave Technologies 51 FINANCIAL CONDITION AND 51 THE REPORTING 51 malignant infectious 51 n h 51 Eligard R 50 Powerwave logo 50 By Thomas Gryta 50 THE RISKS SHOWN 50 Looking Statements Certain 50 TRW Automotive TRW 50 induced pluripotent stem cell 50 fitball courses 50 linear voltage 50 Bioenvision compounds under 50 Topical Interferon Alpha 2b 50 Advancing Drugs 50 g o 50 DIRECTV brands 50 Supplementary Data 50 ANY DECISION MADE OR 50 THE CONTENT 50 incur unanticipated 50 Exelbine 50 EDITORS OF STOCKWIRE.COM 50 Regulatory Disclosure 50 Resverlogix Corp. 49 Rosetta dependence 49 development CommScope combines 49 http:/www.sap.com 49 Private SecuritiesLitigation Reform Act 49 t r 49 Ligand proprietary 49 please visit www.as 49 ViaCyte 49 forward lookingstatements 49 affinity separations diagnostic imaging